IL16 and dementia: Elevated IL-16 levels have been linked to increased risk of white matter lesions in patients with mild cognitive impairment (Kouchaki et al., 2022), and we speculate that they may be associated with decrease white matter and heightened dementia risk in patients with iNPH (Gertje et al., 2023).